主页文献库搜索
Immune microenvironment heterogeneity characterizes biologically distinct KRA...

Zeng(J),Li(Q),Li(K),Yang(L),Xu(L),Wang(W),... Front Immunol 2025-00-00

...PIK3CA (47.1%) and SPOP (23.5%), but their functions were mutually exclusive. In addition, pathways and genes associated...

TIM-3/Galectin-9 Immune Axis in Colorectal Cancer in Relation to KRAS, NRAS, ...

Ochman(B),Kot(A),Mielcarska(S),Kula(A),Daw... Int J Mol Sci 2025-07-14

...PIK3CA-mutated tumors (p < 0.05), while no associations were found with KRAS, NRAS, BRAF, AKT1, or MSI status. Multiplex...

Real-world data of cadonilimab in recurrent or metastatic cervical cancer in ...

Chen(J),Yu(H),Lin(Y),Hu(D),Liu(L),Fan(R),Z... Front Immunol 2025-00-00

...PIK3CA, highlighting the importance of the PI3K-AKT pathway in the antitumor mechanism of cadonilimab. Cadonilimab shows...

Identification and modulation of a PI3K/AKT/mTOR pathway-targeting microRNA i...

Mousavikia(SN),M Matin(M),Bahreyni Tossi(M... BMC Cancer 2025-07-14

...PIK3CA, with remarkable changes in gene expression after irradiation. Transfection and irradiation decreased cell surviv...

Genetic alterations of prostate cancer: in localized and metastatic prostate ...

Yoon(CE),Kang(S),Rhew(SA),Kwon(HJ),Shin(D)... BMC Urol 2025-07-14

...PIK3CA, LRP6, LRRK2, and APOBEC3B deletion. BRCA2, BCL6, and CHEK2 were significant predictors for BCR. CONCLUSION: Our ...

A retrospective study of laryngeal squamous cell carcinoma and the significan...

Kubota(A),Bandoh(N),Goto(T),Kono(M),Sato(R... Mol Clin Oncol 2025-10-00

...PIK3CA in 2 (8%) of these 24 patients. Multivariate Cox proportional hazard analysis revealed that PIK3CA mutation was a...

cfDNA Key genomic markers in HCV-Induced hepatocellular carcinoma in Egyptian...

Khalifa(M),Hmed(AA),Elfeky(KS),Bakry(S),Ha... J Genet Eng Biotechnol 2025-09-00

...PIK3CA. The present study represents the first comprehensive somatic mutation profile in HCC Egyptian patients. This fin...

Inavolisib for HR-Positive, HER2-Negative Advanced Breast Cancer: Clinical Tr...

Arabshomali(A),Goswami(S),Masurkar(PP) Am J Clin Oncol 2025-10-01

...PIK3CA gene. A literature review was conducted to evaluate the safety and efficacy of inavolisib in breast cancer. Studi...

In-depth assessment of BRAF, NRAS, KRAS, EGFR, and PIK3CA mutations on cell-f...

Heidrich(I),Rautmann(C),Ly(C),Khatri(R),Kö... J Exp Clin Cancer Res 2025-07-12

...PIK3CA variants. Overall tissue-plasma concordance was 51.6%, with more extended biopsy-plasma intervals associated with...

Tumor-initiating genetics and therapy drive divergent molecular evolution in ...

Chowdhury(T),Tesileanu(CMS),Kocakavuk(E),J... bioRxiv 2025-07-15

...PIK3CA , PIK3R1 , and NOTCH1 were newly acquired in recurrent oligodendrogliomas and associated with increased mutation ...

上一页 68 69 70 71 72 73 74 75 76 下一页 72 / 共 350

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: product@genelibs.com